Starling Oncology is Changing Oncology for the Better
Starling Oncology (NASDAQ: STLN) is advancing
oncology by delivering highly specialized, value-based cancer care in the
community setting. Formerly known as The Oncology Institute, Starling Oncology
offers cutting-edge, evidence-based cancer care to a population of approximately
2.1 million patients, including clinical trials, transfusions, and other care
delivery models traditionally associated with the most advanced care delivery
organizations.
With more than 400 employed and network clinicians and over 100
clinics and network locations of care across California, Florida,
Arizona, Nevada, and Oregon, Starling Oncology is changing oncology for the
better.